TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Two “optimists” present different visions for rapid progress in cancer research at American Association for Cancer Research annual meeting. Leland Hartwell advocates genome-like project for molecular diagnostics. Andrew von Eschenbach describes “fantasies, dreams, visions” becoming reality. April 9, 2004
TCL Archive Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation August 29, 2014
